Recent updates

Browse recent updates. BMJ Best Practice is continuously updated to provide the latest evidence-based decision support.

  • 28 Nov 2025FDA approves novel antipsychotic lumateperone as a new adjunctive treatment for depressionTopic:Depression in adults
  • 28 Oct 2025AMT-130 gene therapy slows disease progression in patients with Huntington diseaseTopic:Huntington disease
  • 22 Oct 2025FDA approves nerandomilast for treatment of idiopathic pulmonary fibrosis in adultsTopic:Idiopathic pulmonary fibrosis
  • 10 Oct 2025WHO declares mpox emergency overTopic:Mpox
  • 25 Sep 2025Bictegravir-containing antiretroviral therapy (ART) now recommended as preferred option for pregnant womenTopic:HIV in pregnancy
  • 10 Sep 2025US and European guidance recommends updated classifications for UTI in menTopic:Urinary tract infections in men
  • 28 Aug 2025FDA suspends biologics license of live-attenuated chikungunya vaccine (Ixchiq®)Topic:Chikungunya virus infection
  • 14 Aug 2025Nipocalimab approved by FDA for treatment of generalized myasthenia gravisTopic:Myasthenia gravis
  • 04 Jul 2025​Evidence supports cardiovascular safety of testosterone therapy in men with hypogonadismTopic:Hypogonadism in men
  • 13 Nov 2024US FDA approves new treatment for schizophrenia, the first drug with a novel target in decadesTopic:Schizophrenia
  • 06 Aug 2024Updated American College of Gastroenterology guidance includes new fluid resuscitation recommendations for patients with acute pancreatitisTopic:Acute pancreatitis